USD 0.0
(-3.92%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2655.00 USD | 0.0% |
2022 | 2655.00 USD | 0.0% |
2021 | 2655.00 USD | 0.0% |
2020 | 2655.00 USD | 0.0% |
2019 | 2655.00 USD | -9.57% |
2018 | 2936.00 USD | -92.44% |
2017 | 38.85 Thousand USD | 0.0% |
2015 | 26 Thousand USD | 1463782468886095500000.0% |
2014 | - USD | -50.0% |
2013 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2655.00 USD | 0.0% |
2024 Q1 | 2655.00 USD | 0.0% |
2023 Q4 | 2655.00 USD | 0.0% |
2023 Q2 | 2655.00 USD | 0.0% |
2023 Q1 | 2655.00 USD | 0.0% |
2023 FY | 2655.00 USD | 0.0% |
2023 Q3 | 2655.00 USD | 0.0% |
2022 Q1 | 2655.00 USD | 0.0% |
2022 Q2 | 2655.00 USD | 0.0% |
2022 Q3 | 2655.00 USD | 0.0% |
2022 FY | 2655.00 USD | 0.0% |
2022 Q4 | 2655.00 USD | 0.0% |
2021 Q3 | 2655.00 USD | 0.0% |
2021 FY | 2655.00 USD | 0.0% |
2021 Q2 | 2655.00 USD | 0.0% |
2021 Q1 | 2655.00 USD | 0.0% |
2021 Q4 | 2655.00 USD | 0.0% |
2020 FY | 2655.00 USD | 0.0% |
2019 FY | 2655.00 USD | -9.57% |
2018 FY | 2936.00 USD | -92.44% |
2017 FY | 38.85 Thousand USD | 0.0% |
2015 FY | 26 Thousand USD | 1463782468886095500000.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | -100.0% |
2014 FY | - USD | -50.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q4 | - USD | -50.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | -100.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
China Medicine Corporation | 2.73 Million USD | 99.903% |
DH Enchantment Inc. | 613.00 USD | -333.116% |
Exlites Holdings International, Inc. | - USD | -Infinity% |
Itonis, Inc. | - USD | -Infinity% |
MediPal Holdings Corporation | 1.13 Billion USD | 100.0% |
PD-Rx Pharmaceuticals, Inc. | 1.64 Million USD | 99.838% |
Pharmagen, Inc. | 136.97 USD | -1838.381% |
Suzuken Co., Ltd. | 940.54 Million USD | 100.0% |